Minimum Inhibitory Concentration Distributions for Mycobacterium Avium Complex—towards Evidence-Based Susceptibility Breakpoints

International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2016.12.027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rational Choice of Antibiotics and Media for Mycobacterium Avium Complex Drug Susceptibility Testing

Frontiers in Microbiology
Microbiology
2020English

Intra- And Extracellular Susceptibility of Mycobacterium Avium-Intracellulare Complex to Aminoglycoside Antibiotics.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Thioridazine as Chemotherapy for Mycobacterium Avium Complex Diseases

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Mycobacterium Avium Complex Infection Mimicking Lung Cancer

BMJ Case Reports
Medicine
2019English

Identification of Mycobacterium Avium Complex in Sarcoidosis.

Journal of Clinical Microbiology
Microbiology
1996English

Multisite Reproducibility of Results Obtained by Two Broth Dilution Methods for Susceptibility Testing of Mycobacterium Avium Complex

Journal of Clinical Microbiology
Microbiology
2003English

Secondary Mycobacterium Avium Complex (MAC) Pulmonary Disease

2019English

Rapid Radiometric Method for Determining Drug Susceptibility of Mycobacterium Avium-Intracellulare.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

Evaluation of Mycobacterium Avium Complex Clarithromycin Susceptibility Testing Using SLOMYCO Sensititre Panels and JustOne Strips

Journal of Clinical Microbiology
Microbiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy